A 58-year-old female presented with a left breast lump. Mammography and biopsy revealed ductal carcinoma in situ. She underwent wide excision of the lump. Routine blood tests and imaging exams like ultrasound and echocardiogram were normal. Histopathology of the excised lump confirmed focal ductal carcinoma in situ. She tolerated the surgery well and was discharged with drain in situ and medications.
This document discusses chocolate cysts, also known as endometriomas. It provides definitions of endometriosis and discusses its prevalence, pathogenesis, classification systems, implications, clinical presentation, diagnosis and treatment approaches. Some key points include:
- Endometriosis is the presence of endometrial-like tissue outside the uterus, which induces inflammation. Estimated prevalence is 2-10% in the general female population and up to 50% in infertile women.
- The exact cause is unknown but theories include retrograde menstruation and coelomic metaplasia. It can cause painful symptoms and infertility.
- Staging systems include rASRM and Endometriosis Fertility Index (
This document discusses breast lumps and the evaluation process. It covers the anatomy of the breast, history taking, clinical examination techniques, and the "triple assessment" process of ultrasound, mammography, and biopsy to establish a diagnosis. The anatomy section describes the structure of the breast including lobes, ducts, and lymphatic drainage. The examination section provides details on inspecting and palpating the breasts and lymph nodes. The triple assessment discusses the use of imaging like ultrasound and mammography as well as biopsy techniques to diagnose breast lumps.
The document discusses breast anatomy, clinical presentation of breast lumps, and breast cancer. It describes:
- The anatomy of the breast including boundaries, structure, blood supply, lymphatic drainage, and breast quadrants.
- Types of benign and malignant breast lumps based on characteristics like size, consistency, skin changes, and lymph node involvement.
- Risk factors, symptoms, and examination findings for breast cancer including family history, reproductive factors, lump characteristics, and nodal and distant metastases.
- Staging of breast cancer uses the TNM classification of tumor size, lymph node involvement, and distant metastases.
This document provides details from a presentation on ovarian carcinoma including:
1) An introduction defining ovarian tumors and their classification.
2) A WHO classification of ovarian tumors into 9 categories.
3) Details on the clinical signs, symptoms, differentiation and complications of benign vs malignant ovarian tumors.
This document summarizes guidelines for managing ovarian endometriomas. It discusses that endometriomas larger than 3cm should be surgically removed if causing pain or infertility. Complete excision of the cyst is preferable to drainage/ablation to reduce recurrence risk. While surgery provides relief, recurrence rates remain high, so post-operative hormonal therapy for 6 months can help delay recurrence compared to no treatment. Ovarian damage is a risk, so conservative surgery aims to preserve ovarian function where possible.
Suspicious cervix in the era of via 2015 -slide share no-copy Mohammad Emam
This document discusses the definition of a clinically suspicious cervix and how visual inspection with acetic acid (VIA) can help provide an objective definition. It outlines the advantages of VIA over Pap smear testing for cervical cancer screening in low resource settings. The document also summarizes experiences using VIA for screening in Egypt, finding it identified preinvasive lesions but HPV was not the main cause of cervical cancers detected. The conclusion is that VIA can distinguish between less concerning causes of abnormalities from more serious pre-cancers or cancers and should be a routine part of cervical exams to identify suspicious lesions for biopsy or treatment.
Assessment of infertility using hystero laparoscopyNiranjan Chavan
This study assessed infertility using hystero-laparoscopy in 504 patients over 3 years. Key findings include:
Tubal factors were the leading cause of infertility (35%). Hysteroscopy found endometrial polyps in 5% and adhesions in 4%. Laparoscopy found endometriosis in 20% and thickened tubes in 13%. Hystero-laparoscopy allowed diagnosis of factors missed by other tests and endoscopic management such as adhesiolysis, myomectomy, or polycystic ovarian drilling. The study concluded hystero-laparoscopy is a feasible one-time approach for infertility assessment and treatment.
This document discusses the definition, clinical presentation, diagnosis, and management of endometriomas. Key points include:
- Endometriomas are ovarian cysts caused by the growth of endometrial tissue in the ovary.
- They commonly present with pelvic pain and can affect fertility. Diagnosis is usually made by ultrasound or MRI showing characteristic cyst features.
- Treatment involves medical management with hormones or surgery. Conservative cyst removal by laparoscopy is preferred for fertility preservation, while drainage may be used for high-risk cases.
- Both medical and surgical treatments aim to relieve symptoms, but neither has proven clearly superior for long-term outcomes. Treatment should be individualized based on patient factors and
This document discusses chocolate cysts, also known as endometriomas. It provides definitions of endometriosis and discusses its prevalence, pathogenesis, classification systems, implications, clinical presentation, diagnosis and treatment approaches. Some key points include:
- Endometriosis is the presence of endometrial-like tissue outside the uterus, which induces inflammation. Estimated prevalence is 2-10% in the general female population and up to 50% in infertile women.
- The exact cause is unknown but theories include retrograde menstruation and coelomic metaplasia. It can cause painful symptoms and infertility.
- Staging systems include rASRM and Endometriosis Fertility Index (
This document discusses breast lumps and the evaluation process. It covers the anatomy of the breast, history taking, clinical examination techniques, and the "triple assessment" process of ultrasound, mammography, and biopsy to establish a diagnosis. The anatomy section describes the structure of the breast including lobes, ducts, and lymphatic drainage. The examination section provides details on inspecting and palpating the breasts and lymph nodes. The triple assessment discusses the use of imaging like ultrasound and mammography as well as biopsy techniques to diagnose breast lumps.
The document discusses breast anatomy, clinical presentation of breast lumps, and breast cancer. It describes:
- The anatomy of the breast including boundaries, structure, blood supply, lymphatic drainage, and breast quadrants.
- Types of benign and malignant breast lumps based on characteristics like size, consistency, skin changes, and lymph node involvement.
- Risk factors, symptoms, and examination findings for breast cancer including family history, reproductive factors, lump characteristics, and nodal and distant metastases.
- Staging of breast cancer uses the TNM classification of tumor size, lymph node involvement, and distant metastases.
This document provides details from a presentation on ovarian carcinoma including:
1) An introduction defining ovarian tumors and their classification.
2) A WHO classification of ovarian tumors into 9 categories.
3) Details on the clinical signs, symptoms, differentiation and complications of benign vs malignant ovarian tumors.
This document summarizes guidelines for managing ovarian endometriomas. It discusses that endometriomas larger than 3cm should be surgically removed if causing pain or infertility. Complete excision of the cyst is preferable to drainage/ablation to reduce recurrence risk. While surgery provides relief, recurrence rates remain high, so post-operative hormonal therapy for 6 months can help delay recurrence compared to no treatment. Ovarian damage is a risk, so conservative surgery aims to preserve ovarian function where possible.
Suspicious cervix in the era of via 2015 -slide share no-copy Mohammad Emam
This document discusses the definition of a clinically suspicious cervix and how visual inspection with acetic acid (VIA) can help provide an objective definition. It outlines the advantages of VIA over Pap smear testing for cervical cancer screening in low resource settings. The document also summarizes experiences using VIA for screening in Egypt, finding it identified preinvasive lesions but HPV was not the main cause of cervical cancers detected. The conclusion is that VIA can distinguish between less concerning causes of abnormalities from more serious pre-cancers or cancers and should be a routine part of cervical exams to identify suspicious lesions for biopsy or treatment.
Assessment of infertility using hystero laparoscopyNiranjan Chavan
This study assessed infertility using hystero-laparoscopy in 504 patients over 3 years. Key findings include:
Tubal factors were the leading cause of infertility (35%). Hysteroscopy found endometrial polyps in 5% and adhesions in 4%. Laparoscopy found endometriosis in 20% and thickened tubes in 13%. Hystero-laparoscopy allowed diagnosis of factors missed by other tests and endoscopic management such as adhesiolysis, myomectomy, or polycystic ovarian drilling. The study concluded hystero-laparoscopy is a feasible one-time approach for infertility assessment and treatment.
This document discusses the definition, clinical presentation, diagnosis, and management of endometriomas. Key points include:
- Endometriomas are ovarian cysts caused by the growth of endometrial tissue in the ovary.
- They commonly present with pelvic pain and can affect fertility. Diagnosis is usually made by ultrasound or MRI showing characteristic cyst features.
- Treatment involves medical management with hormones or surgery. Conservative cyst removal by laparoscopy is preferred for fertility preservation, while drainage may be used for high-risk cases.
- Both medical and surgical treatments aim to relieve symptoms, but neither has proven clearly superior for long-term outcomes. Treatment should be individualized based on patient factors and
This document discusses breast lumps and their evaluation. It covers breast anatomy, common causes of lumps based on age and other factors, symptoms like pain or discharge, examination findings for lumps and lymph nodes, and initial investigations like mammography, ultrasound, MRI and biopsy. A full evaluation involves considering the patient's history, clinical examination findings, imaging tests and biopsy results.
Ovarian cysts in postmenopausal women are initially assessed through measuring serum CA125 level and transvaginal ultrasound scan. The risk of malignancy is evaluated using the Risk of Malignancy Index (RMI), which calculates a score based on menopausal status, ultrasound features, and CA125 level. An RMI score of 200 or higher indicates a higher risk of cancer and warrants further evaluation with CT scan of the abdomen and pelvis and referral to a gynecological oncology team. While CA125 is the primary tumor marker used to calculate RMI, other markers alone are not sufficient for assessment due to low sensitivity and specificity.
This document discusses adnexal masses in reproductive age women. It provides clinical background and epidemiology of adnexal masses. It discusses ultrasound techniques for evaluating adnexal masses such as 2D ultrasound, Doppler ultrasound, 3D and power Doppler ultrasound. Pattern recognition of benign disease using ultrasound is covered. The document also discusses predicting malignancy using systems like IOTA simple rules and pattern recognition. Characterization of adnexal masses and predicting histopathology and management are key focuses.
Lecture on acute pancreatitis for medical students. Encompasses basic sciences, classifications, principles and tips of management for this potentially deadly condition.
This document discusses the differential diagnosis of pelvic masses according to age group and site of involvement. It describes various benign and malignant causes of pelvic masses including functional cysts, fibroids, ovarian tumors, pregnancy, endometriosis, tubo-ovarian abscess. The diagnosis involves taking a detailed history, examination, and investigations like ultrasound, CA-125. The management depends on the underlying cause and may include observation, medical therapy, surgery or staging laparotomy.
- Ovarian cancer is the 5th most common cancer in women and the most common cause of gynecologic mortality, with an estimated 21,650 new cases and 15,520 deaths in the US in 2008.
- Risk factors include advancing age, infertility, endometriosis, talcum powder use, and genetic susceptibility. Protective factors include oral contraceptive use, parity, and tubal sterilization.
- Screening with transvaginal ultrasound and CA125 is recommended for high-risk women like those with BRCA mutations, but routine screening is not recommended for the general population due to low sensitivity of tests for early detection.
Management of Suspected Ovarian Masses in Premenopausal Women RCOG, 2011Aboubakr Elnashar
The document discusses the management of suspected ovarian masses in premenopausal women. It begins by noting that most premenopausal ovarian masses are benign, but differentiating between benign and malignant masses preoperatively can be problematic. It then describes the types of adnexal masses, ways to minimize patient morbidity including conservative management and laparoscopic techniques, the assessment process including history, exam, blood tests, imaging and risk estimation models, and treatment options including surgery.
Ultrasound is useful for evaluating adnexal masses to determine if they are physiologic cysts, benign tumors, or malignant. Features like size, contents, walls, and blood flow help characterize masses. For example, dermoid cysts appear mixed and contain shadows, while endometriomas look ground glass. Scoring systems combine ultrasound findings with clinical factors to estimate cancer risk and guide management decisions between observation and surgery. Precise terminology and standardized exams are important for accurate assessment and diagnosis of adnexal lesions.
This document provides an overview of breast anatomy, development, hormones, cancer epidemiology, risk factors, diagnosis, staging, pathology, and management. It discusses the following:
- Breast anatomy and development in relation to hormones like estrogen and progesterone.
- Breast cancer is the most commonly diagnosed cancer in women worldwide, with incidence rates increasing rapidly between ages 30-50.
- Risk factors include genetic, hormonal, dietary, and environmental factors.
- Diagnosis involves physical examination, mammography, and biopsies. Staging uses the TNM system to classify cancer extent and severity.
- Management depends on cancer type and stage, and may include surgery, radiation, chemotherapy, hormone therapy,
This document discusses common causes and approaches to evaluating and managing postmenopausal vaginal bleeding. Key causes mentioned include atrophic vaginitis, endometrial hyperplasia, uterine polyps, endometrial cancer, and exogenous estrogen use. The diagnostic approach involves a detailed history, examination, transvaginal ultrasound, hysteroscopy, and biopsy. Initial stabilization priorities bleeding control. Long-term management depends on the underlying cause and may involve hormone therapy, surgery, or chemotherapy/radiotherapy. Counseling supports informed decision making and long-term follow up.
Ovarian cancer is believed to be caused by damage to the ovarian surface during ovulation. Risk factors include nulliparity, early menarche, late menopause, and lack of oral contraceptive pill use or pregnancy. The majority are epithelial cancers, with serous cystadenocarcinoma being the most common type. Treatment involves surgical staging and debulking followed by chemotherapy with carboplatin and paclitaxel. Prognosis depends on stage, with 5-year survival rates of over 90% for stage I disease but only 30% for advanced stage. Follow up after treatment involves monitoring for recurrence every 3-6 months for 5 years.
Cervical cancer is caused by persistent HPV infection that can lead to abnormal cell growth in the cervix. It is diagnosed through screening tests like Pap smear and HPV testing, followed by diagnostic procedures like colposcopy and biopsy if initial tests are abnormal. The FIGO staging system is used to classify cervical cancer on a scale of 0 to IV based on how far the cancer has spread from the cervix.
This document discusses abnormal uterine bleeding and its evaluation and management. It defines normal menstrual bleeding and outlines the risks of endometrial cancer, which rise from 1% at age 50 to 25% at age 80. Evaluation involves history, examination, endometrial sampling and ultrasound. Treatment options include observation, medical management with hormonal therapy, minimally invasive techniques like ablation, and surgery for more severe cases. The goal is to exclude endometrial cancer and atypical hyperplasia.
Optimum approach to patients with gynecological malignancies ver 3.0Vivek Verma
This document discusses the optimum approach to treating patients with gynecological malignancies. It covers risk factors, clinical presentation, diagnosis and diagnostic tests, therapeutic goals, and management including surgery, radiation, and drug therapy for the three main gynecological cancers: endometrial cancer, cervical cancer, and ovarian cancer. National Comprehensive Cancer Network guidelines from 2016 are referenced for treatment recommendations. Supportive care is also discussed to manage side effects from treatment.
Panel Discussion on Post Menopausal Bleeding Lifecare Centre
Panel Discussion on Post Menopausal Bleeding
Moderator
Dr Jyoti Agarwal
Dr Meenakshi Sharma
Panelists
Dr Uma Rai
Dr Raj Bokaria
Dr Ila Gupta
Dr Vandana Gupta
Dr Renu Chawla
Dr Manju Barik
Dr Krishna Gopa
Dr Sharda Jain
This document discusses cervical carcinoma, including its definition, epidemiology, risk factors, screening and prevention methods, diagnosis, staging, and treatment. It notes that cervical cancer is the 4th most common cancer in women worldwide, with over 80% of cases occurring in developing countries. Screening methods discussed include the Pap smear, HPV testing, and visual inspection with acetic acid. Treatment depends on the stage of cancer, and may include surgery such as hysterectomy or cone biopsy, radiation therapy, or chemoradiation for more advanced stages. The document provides details on the FIGO staging system and comparisons between the 2018 and 2009 versions.
This document discusses the investigation and management of postmenopausal uterine bleeding. It describes the most common causes as atrophic vaginitis (60-80%), estrogen treatments (15-25%), and polyps (2-12%). Transvaginal ultrasound is recommended to measure endometrial thickness, with <3mm making cancer unlikely. Additional tests may include saline infusion sonography, hysteroscopy, and endometrial biopsy. Treatment depends on the cause but includes topical estrogen for atrophic vaginitis, polypectomy, and hysterectomy with bilateral oophorectomy for cancer. Recurrent bleeding warrants hysteroscopy and dilation and curettage.
1) Ovarian cysts are common in premenopausal women and are usually benign, with a risk of malignancy around 1 in 1000. Postmenopausal cysts require more evaluation due to higher risk of cancer.
2) Conservative management is recommended for small, unilateral, simple cysts in premenopausal women, with follow up ultrasound. Suspicious cysts based on features like size, complexity, CA125 levels should be referred to specialists.
3) Serial ultrasound can monitor simple, thin-walled cysts under 10cm in postmenopausal women, which often resolve spontaneously. But thicker-walled or larger cysts require further evaluation due to higher cancer risk.
A case of an ovarian tumour pre-operatively thought to be malignant, which was per-operatively diagnosed as benign and later confirmed as a mucinous cystadenoma.
Ob-Gyn Department, BIRDEM-2 General Hospital, Shegunbagicha, Dhaka, Bangladesh
This case review summarizes the presentation, investigations, and management of a 56-year-old postmenopausal female with abdominal pain and breathlessness. Transvaginal ultrasound revealed a large cystic pelvic mass. Her CA125 level was elevated. Based on these findings and her postmenopausal status, her risk of malignancy index (RMI) score was calculated as 75, indicating a high risk of cancer. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy. Histopathology revealed the mass to be a mixed Brenner mucinous tumor of the right ovary, a type of ovarian cancer. For postmenopausal ovarian cysts, the RMI score is used to
This document discusses breast lumps and their evaluation. It covers breast anatomy, common causes of lumps based on age and other factors, symptoms like pain or discharge, examination findings for lumps and lymph nodes, and initial investigations like mammography, ultrasound, MRI and biopsy. A full evaluation involves considering the patient's history, clinical examination findings, imaging tests and biopsy results.
Ovarian cysts in postmenopausal women are initially assessed through measuring serum CA125 level and transvaginal ultrasound scan. The risk of malignancy is evaluated using the Risk of Malignancy Index (RMI), which calculates a score based on menopausal status, ultrasound features, and CA125 level. An RMI score of 200 or higher indicates a higher risk of cancer and warrants further evaluation with CT scan of the abdomen and pelvis and referral to a gynecological oncology team. While CA125 is the primary tumor marker used to calculate RMI, other markers alone are not sufficient for assessment due to low sensitivity and specificity.
This document discusses adnexal masses in reproductive age women. It provides clinical background and epidemiology of adnexal masses. It discusses ultrasound techniques for evaluating adnexal masses such as 2D ultrasound, Doppler ultrasound, 3D and power Doppler ultrasound. Pattern recognition of benign disease using ultrasound is covered. The document also discusses predicting malignancy using systems like IOTA simple rules and pattern recognition. Characterization of adnexal masses and predicting histopathology and management are key focuses.
Lecture on acute pancreatitis for medical students. Encompasses basic sciences, classifications, principles and tips of management for this potentially deadly condition.
This document discusses the differential diagnosis of pelvic masses according to age group and site of involvement. It describes various benign and malignant causes of pelvic masses including functional cysts, fibroids, ovarian tumors, pregnancy, endometriosis, tubo-ovarian abscess. The diagnosis involves taking a detailed history, examination, and investigations like ultrasound, CA-125. The management depends on the underlying cause and may include observation, medical therapy, surgery or staging laparotomy.
- Ovarian cancer is the 5th most common cancer in women and the most common cause of gynecologic mortality, with an estimated 21,650 new cases and 15,520 deaths in the US in 2008.
- Risk factors include advancing age, infertility, endometriosis, talcum powder use, and genetic susceptibility. Protective factors include oral contraceptive use, parity, and tubal sterilization.
- Screening with transvaginal ultrasound and CA125 is recommended for high-risk women like those with BRCA mutations, but routine screening is not recommended for the general population due to low sensitivity of tests for early detection.
Management of Suspected Ovarian Masses in Premenopausal Women RCOG, 2011Aboubakr Elnashar
The document discusses the management of suspected ovarian masses in premenopausal women. It begins by noting that most premenopausal ovarian masses are benign, but differentiating between benign and malignant masses preoperatively can be problematic. It then describes the types of adnexal masses, ways to minimize patient morbidity including conservative management and laparoscopic techniques, the assessment process including history, exam, blood tests, imaging and risk estimation models, and treatment options including surgery.
Ultrasound is useful for evaluating adnexal masses to determine if they are physiologic cysts, benign tumors, or malignant. Features like size, contents, walls, and blood flow help characterize masses. For example, dermoid cysts appear mixed and contain shadows, while endometriomas look ground glass. Scoring systems combine ultrasound findings with clinical factors to estimate cancer risk and guide management decisions between observation and surgery. Precise terminology and standardized exams are important for accurate assessment and diagnosis of adnexal lesions.
This document provides an overview of breast anatomy, development, hormones, cancer epidemiology, risk factors, diagnosis, staging, pathology, and management. It discusses the following:
- Breast anatomy and development in relation to hormones like estrogen and progesterone.
- Breast cancer is the most commonly diagnosed cancer in women worldwide, with incidence rates increasing rapidly between ages 30-50.
- Risk factors include genetic, hormonal, dietary, and environmental factors.
- Diagnosis involves physical examination, mammography, and biopsies. Staging uses the TNM system to classify cancer extent and severity.
- Management depends on cancer type and stage, and may include surgery, radiation, chemotherapy, hormone therapy,
This document discusses common causes and approaches to evaluating and managing postmenopausal vaginal bleeding. Key causes mentioned include atrophic vaginitis, endometrial hyperplasia, uterine polyps, endometrial cancer, and exogenous estrogen use. The diagnostic approach involves a detailed history, examination, transvaginal ultrasound, hysteroscopy, and biopsy. Initial stabilization priorities bleeding control. Long-term management depends on the underlying cause and may involve hormone therapy, surgery, or chemotherapy/radiotherapy. Counseling supports informed decision making and long-term follow up.
Ovarian cancer is believed to be caused by damage to the ovarian surface during ovulation. Risk factors include nulliparity, early menarche, late menopause, and lack of oral contraceptive pill use or pregnancy. The majority are epithelial cancers, with serous cystadenocarcinoma being the most common type. Treatment involves surgical staging and debulking followed by chemotherapy with carboplatin and paclitaxel. Prognosis depends on stage, with 5-year survival rates of over 90% for stage I disease but only 30% for advanced stage. Follow up after treatment involves monitoring for recurrence every 3-6 months for 5 years.
Cervical cancer is caused by persistent HPV infection that can lead to abnormal cell growth in the cervix. It is diagnosed through screening tests like Pap smear and HPV testing, followed by diagnostic procedures like colposcopy and biopsy if initial tests are abnormal. The FIGO staging system is used to classify cervical cancer on a scale of 0 to IV based on how far the cancer has spread from the cervix.
This document discusses abnormal uterine bleeding and its evaluation and management. It defines normal menstrual bleeding and outlines the risks of endometrial cancer, which rise from 1% at age 50 to 25% at age 80. Evaluation involves history, examination, endometrial sampling and ultrasound. Treatment options include observation, medical management with hormonal therapy, minimally invasive techniques like ablation, and surgery for more severe cases. The goal is to exclude endometrial cancer and atypical hyperplasia.
Optimum approach to patients with gynecological malignancies ver 3.0Vivek Verma
This document discusses the optimum approach to treating patients with gynecological malignancies. It covers risk factors, clinical presentation, diagnosis and diagnostic tests, therapeutic goals, and management including surgery, radiation, and drug therapy for the three main gynecological cancers: endometrial cancer, cervical cancer, and ovarian cancer. National Comprehensive Cancer Network guidelines from 2016 are referenced for treatment recommendations. Supportive care is also discussed to manage side effects from treatment.
Panel Discussion on Post Menopausal Bleeding Lifecare Centre
Panel Discussion on Post Menopausal Bleeding
Moderator
Dr Jyoti Agarwal
Dr Meenakshi Sharma
Panelists
Dr Uma Rai
Dr Raj Bokaria
Dr Ila Gupta
Dr Vandana Gupta
Dr Renu Chawla
Dr Manju Barik
Dr Krishna Gopa
Dr Sharda Jain
This document discusses cervical carcinoma, including its definition, epidemiology, risk factors, screening and prevention methods, diagnosis, staging, and treatment. It notes that cervical cancer is the 4th most common cancer in women worldwide, with over 80% of cases occurring in developing countries. Screening methods discussed include the Pap smear, HPV testing, and visual inspection with acetic acid. Treatment depends on the stage of cancer, and may include surgery such as hysterectomy or cone biopsy, radiation therapy, or chemoradiation for more advanced stages. The document provides details on the FIGO staging system and comparisons between the 2018 and 2009 versions.
This document discusses the investigation and management of postmenopausal uterine bleeding. It describes the most common causes as atrophic vaginitis (60-80%), estrogen treatments (15-25%), and polyps (2-12%). Transvaginal ultrasound is recommended to measure endometrial thickness, with <3mm making cancer unlikely. Additional tests may include saline infusion sonography, hysteroscopy, and endometrial biopsy. Treatment depends on the cause but includes topical estrogen for atrophic vaginitis, polypectomy, and hysterectomy with bilateral oophorectomy for cancer. Recurrent bleeding warrants hysteroscopy and dilation and curettage.
1) Ovarian cysts are common in premenopausal women and are usually benign, with a risk of malignancy around 1 in 1000. Postmenopausal cysts require more evaluation due to higher risk of cancer.
2) Conservative management is recommended for small, unilateral, simple cysts in premenopausal women, with follow up ultrasound. Suspicious cysts based on features like size, complexity, CA125 levels should be referred to specialists.
3) Serial ultrasound can monitor simple, thin-walled cysts under 10cm in postmenopausal women, which often resolve spontaneously. But thicker-walled or larger cysts require further evaluation due to higher cancer risk.
A case of an ovarian tumour pre-operatively thought to be malignant, which was per-operatively diagnosed as benign and later confirmed as a mucinous cystadenoma.
Ob-Gyn Department, BIRDEM-2 General Hospital, Shegunbagicha, Dhaka, Bangladesh
This case review summarizes the presentation, investigations, and management of a 56-year-old postmenopausal female with abdominal pain and breathlessness. Transvaginal ultrasound revealed a large cystic pelvic mass. Her CA125 level was elevated. Based on these findings and her postmenopausal status, her risk of malignancy index (RMI) score was calculated as 75, indicating a high risk of cancer. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy. Histopathology revealed the mass to be a mixed Brenner mucinous tumor of the right ovary, a type of ovarian cancer. For postmenopausal ovarian cysts, the RMI score is used to
This document discusses the case of a 46-year-old post-menopausal woman presenting with abdominal distension and discomfort. Imaging revealed a large pelvic mass arising from the left ovary. Frozen section during surgery was suggestive of malignancy or adenocarcinoma. Histopathological examination of the surgical specimens confirmed an infiltrating adenocarcinoma involving both ovaries and lymph nodes, consistent with a Krukenberg tumor from a gastric primary cancer. Secondary tumors of the ovary (STOs), such as Krukenberg tumors, account for 6-10% of ovarian cancers and most commonly arise from stomach, colorectal, breast and appendiceal primary cancers.
This document provides an overview of various imaging modalities and techniques used to image the endocrine and genitourinary systems. It describes the normal anatomy, imaging indications, and key findings for structures like the pituitary gland, thyroid gland, pancreas, kidneys, adrenal glands, prostate, ovaries and female pelvis. Specific modalities covered include MRI, CT, ultrasound, mammography, intravenous urography, cystourethrography and hysterosalpingography. Example images are provided to illustrate normal anatomy on different exams.
- A 45-year-old female presented with a neck mass and chest wall mass. Imaging showed bilateral pulmonary nodules and a lytic rib lesion.
- FNAC of the thyroid showed nodular goiter. FNAC of the chest wall was suggestive of round cell sarcoma.
- She has a diagnosis of poorly controlled toxic nodular goiter, stage IV soft tissue sarcoma with pulmonary and rib metastases, and a need to rule out thyroid cancer. Biopsy of the chest wall mass is planned for further evaluation.
Abnormal uterine bleeding (AUB) refers to any deviation from normal menstruation in terms of frequency, duration, or amount of bleeding. The document discusses various types of AUB and their potential causes, both organic and systemic. It also outlines the diagnostic approach, including medical history, physical examination, laboratory tests, ultrasound, and other imaging procedures. Treatment depends on the individual's age and may involve general measures, medical options like hormones or antifibrinolytics, or surgical interventions.
Yassin is a 3 year old Saudi boy who presented with upper respiratory tract infection, pallor, loss of appetite, headache, weight loss and decreased activity over 2 weeks. On examination he was pale but stable. Tests found anemia, thrombocytopenia and an abdominal mass. Imaging revealed a large right hepatic mass concerning for neuroblastoma with paraortic lymphadenopathy. Biopsy confirmed stage 4 high-risk neuroblastoma with bone marrow infiltration. Treatment involves chemotherapy, radiotherapy and surgery to prepare for bone marrow transplant. Neuroblastoma risk stratification is based on histology, MYCN status, stage and other factors to determine appropriate therapy.
Yassin M. Alsaleh, a 3-year-old Saudi boy, presented with weight loss, pallor, decreased activity, and fever for 2 weeks. Imaging showed an abdominal mass and bone marrow involvement. Biopsy confirmed stage 4 neuroblastoma with bone marrow metastases. Neuroblastoma is a cancer of the sympathetic nervous system that typically presents in children aged 5 or younger. Risk stratification guides treatment, which may include chemotherapy, surgery, radiation therapy, stem cell transplant, or immunotherapy depending on disease stage, age, genetics, and response to initial therapy. Complications can include cord compression, organ dysfunction, infection, and treatment side effects.
Ca breast management (according to NCCN guidelines)Pirah Azadi
Breast cancer is the second leading cause of cancer deaths worldwide, with over 1 million new cases annually. The document outlines guidelines for managing breast cancer according to stage from the National Comprehensive Cancer Network (NCCN). For early stage cancers, treatment involves surgery such as lumpectomy with or without radiation. For advanced stages, management includes chemotherapy, hormone therapy, targeted therapy and surgery as appropriate. Reconstruction options are discussed as well as follow up care and risk reduction strategies.
Drs. Rossi and Shreve’s CMC Abdominal Imaging Mastery Project: November CasesSean M. Fox
Dr. Brian Shreve is an Emergency Medicine Resident and Dr. Isolina Rossi is a Surgery Resident at Carolinas Medical Center in Charlotte, NC. They are interested in medical education. With the guidance of Drs. Kyle Cunningham and Michael Gibbs, they aim to help augment our understanding of emergent abdominal imaging. Follow along with the EMGuideWire.com team as they post these monthly educational, self-guided radiology slides on:
Enterovesical Fistula
Abdominal Aorta Aneurysm
Aortic Dissection
4 cases of pelvic mass are discussed .Adnexal mass invilves masses arisinf from ovary,fallopian tube,uterus,bowel and some miscellenious masses.USG is used to detect its size and the origin.Histopathological findings are diagnostic.
A 24-year-old female presented with rectal mass. Imaging showed a large heterogeneous pelvic mass infiltrating the cervix, vagina, rectum and surrounding structures. Biopsies of the rectal mass showed glandular structures with atypical cells. Differential diagnoses included rectal endometriosis, tubular adenoma or carcinoma. Immunohistochemistry was recommended to help distinguish between endometriosis and malignancy. Further biopsy or resection was also suggested to make a definitive diagnosis.
This document summarizes the case of a 62-year-old female patient who presented with a lump in her right breast. On examination, a 4 cm irregular, mobile lump was detected. Investigations including mammography and biopsy confirmed a diagnosis of invasive ductal carcinoma. The patient underwent a modified radical mastectomy with axillary clearance. Histopathology of the specimen found grade 2 invasive ductal carcinoma with clear margins and no lymph node metastasis. The final diagnosis was invasive ductal carcinoma of the right breast, stage T2N0M0.
Uterine fibroids are benign tumors that develop from the muscular layer of the uterus. They are quite common, affecting 20-40% of women. While the exact cause is unknown, risk factors include genetic factors, hormones, and growth factors. Fibroids can be asymptomatic or cause heavy bleeding, pain, and pressure symptoms. Diagnosis involves physical exam, ultrasound, MRI and other imaging tests. Treatment options range from observation and medication to minimally invasive procedures like uterine artery embolization and myolysis to more invasive options like myomectomy and hysterectomy. Fibroids may also complicate pregnancy by increasing risks of miscarriage, preterm labor, and difficult delivery. Their removal during c-section is sometimes recommended if interfering
APPROACH TO A BREAST CANCER CASE IN SURGICAL PRACTICEabinashchihnara1
The document summarizes information about breast cancer presentations and management. It describes common symptoms like lumps, nipple discharge, and pain. It provides details on patient history, risk factors, diagnostic workup including mammography and biopsy, staging, and treatment options like surgery and adjuvant therapies. Key points covered include distinguishing benign from malignant findings, hereditary risk factors, and predictive markers like hormone receptors that determine treatment responses.
Testicular seminoma with lung and pleural metastases.
Findings:
- Chest X-ray: Multiple round well defined opacities ("cannon ball metastases") in both lungs with right sided pleural effusion.
- CT chest: Enhancing right testicular mass with multiple enhancing lung nodules and right pleural effusion.
Important differentials:
- Non seminomatous GCT (teratoma, embryonal cell carcinoma etc.)
- Lymphoma
- Metastatic disease from other primary
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
5. Personal Demographic History
• Name: Mrs. Ann Felix
• Age: 58 years
• Gender: Female
• Department: Obstetrics & Gynaecology
• Consultant: Dr. Pearl
• Hospital ID: AA2020196
• IP No.: IPR0072707
• Date and time of Admission: 01st July 2020 10:24 AM
6. History of presenting illness
-Patient presented with left sided breast lump since 2 weeks gradually
Increasing in size.
-The lump is irregular in shape, tender and immobile, occasionally
painful
-There is no discharge from the nipples and no skin changes involved
-Mammography performed showed a 2.2 x 1.7 cms irregular nodular
lesion in the outer and upper quadrant of the left breast under
BIRADS III category.
-Trucut biopsy showed Focal ductal carcinoma in situ.
-Now admitted for surgical intervention and management.
7. Past
History
Medical
History
Family
History
Obstetric
History
Personal
History
Past Medical
history:
Hypertension
on treatment
since 10 years
Past Surgical
history: no
history of any
surgery
Current
medications:
LnBloc- 10 mg
on OD since
10 years
Allergies: No
known
allergies
Patients’
mother has
hypertension
and Diabetes
mellitus
Menstrual history:
menopause
OBH: P2L2-
FTND –L1-
Female – 29 years
-L2- Male- 27
years
Married life: 30
years
1st child from 5 siblings
Occupation:
Laboratory
technologist
Patient is non-smoker
and non- alcoholic
Patient has no
addictions of
drugs
8. Family History of Breast Ca
1st
Generation
Maternal
1st
Generation
Paternal
2nd
Generation
Patient
Breast
Cancer
No Cancer
10. General Examination
Pallor - No Pale color found on the skin and conjunctivae of the eyes.
Icterus – No yellowish pigmentation found on the skin, tissue and
body fluids.
Cyanosis – No bluish discoloration are seen on the Lips, Nose,
Cheeks and Oral cavity.
Clubbing – No clubbing seen in Fingernails and Toenails.
Lymphadenopathy – Swelling in the left axillary lymph nodes.
Edema – No swelling on the hands and feet
12. Clinical Breast Examination: Inspection
• Symmetry- Size,
Shape, Position
Both breasts are symmetrical in size, shape and
position
• Skin No visible skin abnormalities , no nodules, no
ulceration, no texture difference, no dimpling,
no skin discoloration, enlarged veins
• Nipples and areolae Nipples present at both sides. Not retracted , no
accessory nipples, nipples dark brown in color,
central in position, no discharge is seen
• Hands by the
side/raisedabove
head
Axillary lymph node enlargement seen , no
distended veins and no muscle wasting
13. Clinical Breast Examination: Palpatation of Lump
• Temperature Warm
• Tenderness Present on left breast
• Site Left upper outer quadrant
• Size 2 x 2 cms
• Shape Round
• Margin Irregular
• Relation to skinand
underlying muscles
Hard, immobile and fixed
Palpate
Circles Wedges
Lines
14. Systemic
Examination Respiratory system
Inspection Shape of the Chest – Bilaterally symmetrical and Elliptical in cross
section.
Movement of the chest – Equal on both side
No abnormalities on the chest • No Tracheal deviation are present.
No Abnormalities in Upper respiratory system.
Palpation Surface temperature is afebrile. No abnormalities in Apical Impulse.
Percussion Percussion done on entire lung field., No any dullness are found.
Auscultation No Abnormal sounds
15. Systemic
Examination Cardiovascular system
Inspection No abnormalities on the chest
JVP is normal
Palpation No any abnormalities in apex beat.
Thrill and Heave are absent.
Percussion No abnormalities found in percussion done on 3rd,4th and 5th
intercoastal space
Auscultation Heart sounds are normal.
16. Systemic
Examination Per Abdomen system
Inspection No any abnormal signs are seen on the abdomen
Palpation Superficial and deep palpation are done and no
abnormalities are found.
Percussion Percussion over the abdomen was given and no Fluid thrill
Found.
Auscultation Bowel sound are heard.
No abnormal sounds are present.
17. Systemic
Examination
Central nervous system and
neuromuscular system
Patient is conscious and oriented
Clonus absent
No reflex abnormalities hyperreflexia/hyporeflexia/areflexia
due to CNS metastasis or electrolyte disturbance
21. TEST PARAMETERS RESULT REFERENCE
V.D.R.L Non Reactive
HIV 0.09 Non reactive less than 1
HBsAg 0.25
Anti HCV 0.06 Non reactive less than 1
(LFT) TOTAL BILLIRUBIN 0.85 mg/dl 0.2-1.3 mg/dl
Direct bilirubin 0.18 mg/dl 0.0-0.3 mg/dl
Indirect bilirubin 0.67 mg/dl
Aspartate Amino
Transferase (SGOT)
29 U/L < 31 U/L
Alkaline Phosphatase
(ALP)
92 IU/L 25-140 IU/L
Alanine Amino Transferase
(SGPT)
41 U/L < 31 U/L
30th June 2020
22. TEST PARAMETERS RESULT REFERENCE
Routine Urine Analysis
Appearance Slightly Cloudy
Colour Yellow
Glucose Negative
Bilirubin Negative
Ketone Negative
Specific Gravity 1.030 1.01-1.035
pH 6.0 4.6-8.0
Urobilinogen Normal
Pus cells 0-2 cells/hpf 0-5 / hpf
RBCs Nil 0-2 / hpf
Epithelial cells Occasional 0-2 /hpf
Crystals and casts Nil
30th June 2020
30. • BI-RADS 0, inconclusive results
requiring further mammography;
• BI-RADS 1: no areas of
architectural distortion, suspicious
calcifications, or masses (tumor
was absent);
• BI-RADS 2: simple cysts, secretory
calcifications, calcified
fibroadenomas, implants, fat-
containing lesions, and
intramammary lymph nodes
(benign tumor);
• BI-RADS 3: a solitary mass of
punctate calcifications, or a
circumscribed and non-palpable
mass, or focal asymmetry
(probably benign);
• BI-RADS 4: suspicious for
malignancy
• BI-RADS 5: highly suggestive of
malignancy
31. Patient underwent mammography
examination with relevant
preparations
Patient was explained about the
procedure beforehand
Bilateral breasts were examined
the examination took about 15 mins
The images were sent to the
radiologist for reporting
32. Mammogram report
Fibro fatty tissues noted in both breasts
Irregular well defined homogenous nodular opacity lesion
measuring 2.2 x 1.7 cms noted in outer and upper quadrant of
the left breast
Retro mammary spaces is clear bilaterally , nipple and areolar
regions appear normal ; skin and subcutaneous tissues are
normal; Left axillary lymph node with benign morphology
Mammogram of both breast were performed, Cranio-
caudal and Medio-lateral oblique views are obtained
Impression: Irregular nodular lesion in upper and outer
quadrant in left breast suspicious for malignancy, BIRADS ‘III’
category
Suggested sonomammogram and FNAC for further evaluation
24th June 2020
33.
34.
35. Ultrasound-guided Tru-cut
needle biopsy is a well-
tolerated and reliable
procedure for providing a
tissue diagnosis of
malignancy before definitive
treatment, and obviating the
need for formal
excision biopsy of lesions for
which there is a low index of
suspicion.
36. Histopathology test report
Tissue fixation: Adequate
Macroscopy description: Specimen contains of four grey- white bits of
tissue, measuring 0.3 to 0.7 cms in two sections named A,B
Microscopy Description:
Block ‘A’- the section depicts tissue cores comprising of fibrous and
adipose tissue components. A single tiny bit shows two compressed
ductal structures which are lined by epithelial cells showing moderate
nuclear atypia, hyperchromasia and absent nucleoli
Within intact basement membrane – suggestive features of Ductal
carcinoma in situ (DCIS). There is dense periductal lymphoid infiltration,
no evidence of invasive malignancy
Nature of the specimen: Trucut Biopsy
Clinical Data: K/C/O left breast lump
Specimen identified by patients’ name and accession number on the
container;
26th June 2020
37. IMPRESSION:
Focal Ductal Carcinoma In Situ, intermediate grade
NHS BSP Category- B4
Section ‘B’ – the section reveals fibro adipose tissue
components and skeletal muscle fibers of normal
morphology with separate small fragment of tissue shows a
few ductal/lobular tissue lined by bilayered epithelial
membrane- within normal limits. No features of malignancy
38.
39. USG of Abdomen and pelvis
Kidneys: both kidneys normal
Right kidney: 8.0 cm
Left kidney: 8.2 cm
Pelvi-calyceal systems: Normal
Bladder: Normal
Uterus: anteverted and normal
Ovaries: Normal
Impression: Fatty liver, no other significant abnormality
detected
Liver: shows increased parenchymal echogenicity
Spleen: Normal
Portal venous system: Normal
Hepatic veins: Normal
Biliary system : Normal
Pancreas: Normal
30th June 2020
40. Chest X-ray report
Chest X-ray PA View
Findings
• Bilateral lung fields are clear
• The cardio mediastinal contours are
within the normal limits
• The hila are normal
• Bilateral costophrenic angles are normal
• Bony thorax appears normal
Impression: No significant abnormality
detected
30th June 2020
41. 2D ECHO
Normal cardiac chambers
Normal valves
Normal RV and LV systolic
functions
Mild pulmonary
hypertension
No clot/RWMA
30th June
2020 ECG
ECG showed normal
rhythm
42. Physician opinion sought for
fitness for surgery
With routine pre-operation
procedures and with prior
consent the patient underwent
Wide excision of left breast lump
under general anesthesia
43. WIDE EXICISION OF LUMP DONE
UNDER GA
● Lump in upper outer quadrant of left
breast was removed with skin over
tumor unto deep muscle
● Around more than 1 cm margin
given in all directions with medial
margin excision
● Drain placed, wound closed in layers
● The specimen sent for HPE
44. POST- PROCEDURE
TREATMENT
• Patient withstood the procedure well
• Patient treated with IV fluids, IV antibiotics, antiemetics,
analgesics, PPI’s and other supportive medications
• Treatment given:
• Inj. Taxim 1 gm IV/ATD 1-0-1
• Inj. PAN 40mg IV/ 1-0-1
• Inj. PCT 100ml IV STAT
• Inj. Emeset 1 amp IV STAT
• Inj. Tramazac 1 amp 1-1-1
• Tab LN BLOC 10 mg 0-0-1
• Ward stay was uneventful hence was discharged in stable
condition with drain in situ the following morning
( 02/07/2020)
45. Condition of patient during discharge : Patient was
stable, wound healthy and dressing was done
Advice on discharge:
Tab. Taxim- O 200 mg 1-0-1 x 5 days
Tab. Ultracet 1-1-1 x 5 days
Tab. Pan 40 mg 1-0-1 x 5 days
Drain care